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INTRODUCTION   
Climate change and environmental pollution have evoked a global concern   as the second
leading cause of death of non-communicable diseases (NCDs) (1).  Particulate matter,
primarily the ambient particulate matter (PM; either coarse (i.e., PM10) or fine particulate
matter (i.e., PM2.5 and PM1)), as  a classical form of air pollutants,  largely draws NCD
concerns and has been  broadly studied for its adverse impact (2). Amid heightened
interest recently, the increasing attention worldwide paid to PM  focuses not only on  acute
health problems such as respiratory and allergy, but also on the associated long-term health
conditions such as diabetes, cancer, stroke,  chronic kidney disease (CKD) and it’s
progression.  Since 2008, the first four diseases of main burden NCDs (e.g., cardiovascular
disease, diabetes, cancer, and chronic respiratory diseases) were prioritized on  the Global
NCD Action Plan; the renal disease  moved  into the latest implementation roadmap of
WHO's for NCD prevention and control, given   CKD has become  a worldwide health
crisis.   
According to the Global Burden of Disease study (2017), around 697.5 million (9.1%)
people worldwide have chronic kidney disease, and more than one-third of those are in
Asian countries(3). Additionally, the trend has moved upward since 1990(4). 
Consequently, it has been several years since the evidence for classic kidney disease or a
medical kidney condition (i.e., diabetic or hypertensive CKD) is very instructive.
However, the incidence of CKD is still increasing.  It is clear that there are multi
phenomena with multiple causes. So, many countries have increasingly provided insights
into other health determinants for key elements that act as CKD risk, particularly the effect
of PM. In fact, a previous study has been discovered changing membranous nephropathy
and also consequently accelerated kidney function fast declining caused by long-term
exposure to PM2.5 or may develop to intensify the disease progression(5).
Similarly, a large-scale cohort study undertaken in the United States yielded similar results
by demonstrating that the PM2.5 concentration increase every ten micrograms per cubic
meter was associated with the increased incident as well as progression CKD around  
26–28%(6). However, it cannot be generalized because the mean PM2.5 concentrations in
America seem to be relatively low compared with other regions (e.g., North Africa, South
Asia, and East Asia)(7). Additionally, a recent study determined that there was different
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CKD risk regarding geographic disparities related to the variation of PM2.5
concentration(8).   
Therefore, as regards different geographical features, combining them to generate a
comprehensive understanding of this environmental health risk is needed. It will be a
better way to assist delayed progression or even halt its worsening into an incurable
condition. So far as widespread as the problem is, reviews of environmental determinants
of health in chronic kidney disease of air pollution origin are limited as well as it is often
not reported and even rare broadly available when compared to the main NCDs related to
air pollution, i.e., heart or lung disease.   
It is not yet twenty years that scoping review has become a buzzword considerably since
Arksey and O’Malley have developed the initial framework in 2005(9). There are typically
six stages existing in their original framework that should be followed accordingly. It starts
with the first step of identifying the research question and continuing steps 2-6, including;
identifying relevant studies, studying selection, charting the data, collating, summarizing,
reporting the results, and an optional consultation exercise, respectively, until the
reviewing is complete.  
Scoping reviews are generally recognized as strategies for evidence review and
information synthesis that complement other summative reporting types such as systematic
review or meta-analysis. Despite broadly similar viewpoints about research synthesis
between scoping and systematic reviews, scoping review is employed for this paper to map
the broadening evidence base to aggregate the current state-of-knowledge about
environmental effects on kidney disorders. Specifically, this scoping review study aims to
provide a comprehensive overview of pollution-related impacts on CKD, and more
broadly on general human health,  by exploring and synthesizing the existing scientific
evidence assessing the association between ambient particulate matter (PM2.5, PM10, and
PM1) and CKD risk.   
 
METHODS
This scoping review is based on methodological guidance developed by the Joanna Briggs
Institute (JBI) scoping review methodology together with an outline of the Arksey and
O’Malley’s framework(9). Thus, the following five-steps are used in the study: (i)
establishing the core research question, (ii) identifying related studies, (iii) determining
studies that meet the eligibility criteria, (iv) data extraction, and (v) collating,
summarizing, and reporting the research finding. Whilst the consultation option might be
not implemented.  
Thus, according to the Arksey and O’Malley’s conceptual framework together with
an outline of the JBI manual, the protocol design will be an array of protocol information
as following: 
i. Identifying the Research Question
Using PCC mnemonic recommended by the Joanna Briggs Institute (JBI) scoping review
methodology to formulate research questions including:
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a. Population: The population burden of chronic kidney disease. Indeed, it will not be
required to enter into the contribution of this review as in further detail
elsewhere within this protocol. 
b. Concept: Chronic Kidney disease and its progression,
c. Context: Particulate air pollution both PM2.5, PM10, and PM1
Therefore, the following questions will be used to guide this review; 
1. What is the association between ambient particulate matter (PM2.5, PM10, and
PM1) and CKD risk-namely what are profiles of CKD progression and mortality risk
in terms of its associated with PM? 
2. What research methods or techniques are used to determine the association or
collect data or carried out in the literature?  
3. How are the characteristics of these associations determined according to their
geographic origin of particulate matter (i.e., compare and contrast countries using
economic categories to distinguish -namely defined as developed countries and
developing countries). 
ii. Identifying  Relevant Studies
The process of performing a literature search will be in collaboration between the
researcher and a health sciences informationist.
The search query will be initially done on MEDLINE/PubMed to obtain a broad overview
of the mandatory information followed by translation into the other relevant literature
databases. The final comprehensive searches were developed by the informationist
(K.M.S.) from inception to 9/20/21 in PubMed, Embase (Elsevier), Environmental Science
Index-  Pollution Abstracts (Proquest) , CINAHL Complete (EBSCO), Scopus (Elsevier),
and Web of Science (SCI-EXPANDED, SSCI, ESCI, CPCI-S). The team supplemented the
comprehensive literature searches with searches in the Environmental Protection Agency,
Mednar, and clinicaltrials.gov to identify relevant grey literature. In order to minimize the
possibility of missed studies, references for all included studies were reviewed, and cited
references of the included studies were also reviewed. The resulting citations were moved
to the citation manager Endnote 20 (Clarivate Analytics) for multipass duplicate detection
and removal.
The searches were built around two main concepts: particulate air pollution and chronic
kidney disease. Each search consisted of a combination of controlled terms appropriate for
the selected databases and keywords. A human limit was added as a third concept in the
databases where this function was possible. A source type limit was also used in Scopus.
See Appendix I for PubMed search strategy. The final reproducible search strategies and
exported search files will be deposited in University of Michigan's institutional data
repository, Deep Blue Data.
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The studies will be included in this review, such as observational studies (such as
cross-sectional, cohort, case-control, and nested case-control studies ), surveys,
quasi-experiments, and true experiments (randomized controlled trials).   In addition,  it
could expand to include qualitative studies.
Within the query, the online evidence from observational studies, non-randomized
comparison studies, and randomized controlled trials (if available) by matching study
terms or keywords will be included as shown in Table 1.
For organizing citing quality, these citations will then link to the complete reference if
detailed information is not applicable, which will be excluded.
TABLE 1:  Study  sources of evidence
Inclusion Exclusion
Big data analysis Scoping reviews
Observational studies Systematic review and meta-analysis
Randomized controlled trials
Grey literature (conference proceedings,
reports, dissertations)
iii. Selection of Eligible Studies
To properly select the evidence synthesis with coverage of CKD progression and its
mortality risk profiles related to either PM2.5, PM10, and PM1 particles, thus it should be
eligible based on inclusion/exclusion criteria.
As stated in the Joanna Briggs Institute (JBI) scoping review methodology, once again,
PCC mnemonic will be used as crucial recommendations for setting up each eligible
criteria. Therefore the key element of this section including; 
Population: This review will contribute no specific population on account of consideration
more broadly to chronic diseases on the population burden of chronic kidney disease.  
Concept: CKD
As the study objective requires determining the relevant literature describing the
relationship between specific pollutants exposure and the subsequent risk of
developing CKD, features of chronic kidney diseases will be focused as a concept of this
review.  According to the definition and classification of CKD in which recommended by
the Kidney Disease Quality Outcome Initiative (K/DOQI)(10) that can be briefly defined
as follows: 1) there is clinical apparent of either kidney damage or declined kidney
function, 2) decreased glomerular filtration rate (GFR) as lower as 60 mL/min/1.73 m2 and
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both of criteria must have existed over the cut-off point of  3 months last. As eligibility
concept criteria, the eligible study must be meet the following criteria:
Inclusion: 
● Populations with CKD or ESRD, or renal dysfunction with its progression (Staging
1-5)
● The estimated glomerular filtration rate (eGFR) is reported.
● Specific age as an adult because adults are most likely to have chronic adverse
effects with exposure to PM2.5, PM10, and PM1 rather than children. 
Exclusion:
● Populations with acute kidney injury (AKI)
● CKD patients who have undergone renal replacement therapy (dialysis or
transplantation) 
Context: Particle air pollution
The term particles air pollutants, PM2.5, PM10, and PM1,  are defined as particle size which
is less than or equal to 2.5 micrometers in diameter, 10 micrometers in diameter, and
diameter less than one-millionth of a meter, respectively. As eligibility context criteria, the
eligible study must be meet the following requirements:
Inclusion: 
● Particulate (PM2.5, PM10, and PM1), primarily the fine particulate matter (PM2.5 and
PM1) as well as coarse PM (i.e., PM10) in terms of affecting to health with its
levels as  major air pollutants,
● Outdoor air pollutants exposure
Exclusion: 
● Returning to the study's aim, specific kinds of air pollutants will be initiated only.
Other exposome such as chemical, water or soil pollution and even indoor air
pollution will not be included.
iv. Data Extraction
Data were extracted manually from included papers included in the scoping review by two
or more independent screeners and then proceeded to the next step, which is the data
extraction stage by using the data extract utility. Data elements (features) collected and
used in each study will be identified. First, identify common data elements (CDE) across
the majority of the reviewed studies. Then, try to extract the data (values for each of these
variables from each study). Moreover, extracting qualitative data will be performed for the
information that some studies will share their data. And then, we can try to “harmonize &
aggregate” the data across studies. Additionally, we can also try to look for de novo
associations between CKD and air pollution (PM). A draft extraction form is initially
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provided  (see Appendix II). This form is able to further customize in accompaniment
with the process of extracting data from each included evidence source. 
Chartering the data
The data extracted will include the table layout with the necessary information as in
the following fields (Table 2). In addition, this form can further be customized in
accompaniment with the process of extracting data from each included evidence source.
TABLE 2:  The table layout for data fields
Field order Filter criteria/ Description
Authors and year of publication
Geography or origin/country of
origin (where the source was
published or conducted) 
Regarding the spatial and temporal distribution of
interesting events, data of country of origin,
geography, and even study periods will be included. 
Participants/Population and
sample size within the source of
evidence (if applicable)
These will also be retrieved; the reason is that there
is evidence for ethnic differences that are affected by
the progression of CKD. 
Concept As mentioned earlier in the background section.
Context Including; specific levels of pollution. Data
extraction will be sorted into PM2.5, PM10, or PM1.
A subset of context:
● The environmental
agencies 
The environmental agencies where are the
information sources about pollutant sources and their
level (e.g.,Real-time Air Quality Index:AQI).  
● Season and regional
weather 
Because  pollution affected by these factors
● Monitoring stations It was the location or area where the levels of PM
were measured (e.g., the ground monitors, satellite
assessments).
Study methods e.g., prospective or descriptive study
Aims/purpose
Statistical methods What type of statistical analysis was undertaken?
Outcomes Reviews focusing on risk effect for the disease
progression, rather than its mortality; therefore, study
finding is a rate of CKD progression and details of
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these (e.g., how measured or evaluated) (if
applicable)
v. Collating, Summarising and Reporting the Result
Following a completed literature search, The researchers will assemble all majority data
sources and remove the duplicate reference before uploading all citations into the citation
management program (Endnote Version 20/2021.(Clarivate Analytics, PA, USA)). 
Following the test out stage, multiple screening of the titles and abstracts will then be
skimmed and scanned by two or more independent reviewers for assessment which one
meets the inclusion criteria or against the trial exclusion criteria for the review.
The full text of potentially relevant papers will be identified and entered into an online
program tool for conducting systematic review (The Joanna Briggs Institute System for the
Unified Management, Assessment and Review of Information:JBI SUMARI)(11). 
Additionally, any reason for exclusion must be recorded. When disagreements regarding
no clear consensus among reviewers arise, seeking out experts' opinions or
consensus-based discussion is required. 
A Preferred Reporting Items for Systematic Reviews and Meta-analyses extension for
scoping review (PRISMA-ScR)(12) flow diagram will be employed for visual expression
in article selection stages according to inclusion and exclusion.
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APPENDICES
Appendix I: Search strategy
PubMed was searched as the initial source of information.
1.
"Glomerular Filtration Rate"[Mesh] OR "Blood Urea Nitrogen"[Mesh] OR "Renal
Insufficiency, Chronic"[Mesh] OR "Renal Insufficiency"[Mesh:NoExp] OR "Kidney
Failure, Chronic"[Mesh] OR "Cardio-Renal Syndrome"[Mesh] OR Kidney[tiab] OR
Renal[tiab] OR glomerular[tiab] OR eGFR[tiab] OR CKD[tiab]  OR ESRD[tiab] OR
"Blood Urea Nitrogen"[tiab] 
2.
"Inhalation Exposure"[Mesh] OR "Air Pollution"[Mesh] OR "Particulate
Matter"[Mesh:NoExp] OR "Smog"[Mesh] OR "Air Pollutants" [Pharmacological Action]
OR  "Air Pollutants"[Mesh] OR "Smoke"[Mesh] OR ((Air[tiab] OR airborne[tiab]) AND
(quality[tiab] OR Pollution[tiab] OR Pollutants[tiab] OR pollutant[tiab])) OR "Particulate




(1 AND 2) NOT 3
10
Appendix II: A draft extraction form
We have designed and piloted a data extraction form using Google Forms. By using the
following link: https://forms.gle/iwp5WLvpLT8uzNgh7
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